GlaxoSmithKline on Thursday said that a pre-clinical analysis of the antibody-based COVID-19 has indicated that the drug also works against the new Omicron variant. Further tests will be carried out on the sotrovimab therapy to firm up the results, GSK said in a statement.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/31lE386
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» GSK says antibody drug 'Sotrovimab' works against Omicron
https://ift.tt/eA8V8J
No comments:
Post a Comment